Trials / Unknown
UnknownNCT03799029
Effects of a Cognitive Training Program With Game Elements Among ADHD
Effects of a Cognitive Training Program With Game Elements and a Reward Feedback System on Children, Adolescents and Adults Presenting ADHD: an Experimental Study. A Multi-centred Study: Neuchatel, Fribourg and Lausanne
- Status
- Unknown
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 240 (estimated)
- Sponsor
- University of Fribourg · Academic / Other
- Sex
- All
- Age
- 6 Years – 65 Years
- Healthy volunteers
- Accepted
Summary
This study examines the impact of cognitive training among participants with ADHD in Switzerland
Detailed description
The main aim of the experimental study is to investigate cognitive functioning, behavioral and neural levels in ADHD, both before and after cognitive training where there has been the addition of motivation elements. Near and far transfers effects of this new program are evaluated. For far transfers, ambulatory assessment is used to improve ecological validity. Neural activity has rarely been examined in cognitive training with ADHD participants, and that is why this study also includes FMRI measures. Long-term effects, defined as three and six months following the completion of cognitive training, are also investigated. This study focuses on children, adolescents and adults with ADHD. Indeed, cognitive training effects have been rarely studied over the lifespan.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Cognitive training | Participants will train at home during 25 sessions (about 45 minutes each) over a maximum of 5 weeks. Investigators will verify compliance via Internet and call participants and their legal guardians once a week. A reward system will be established with participants. Five sessions of metacognition (1 hour each) are added. |
Timeline
- Start date
- 2019-02-20
- Primary completion
- 2021-06-01
- Completion
- 2023-12-01
- First posted
- 2019-01-10
- Last updated
- 2019-01-10
Locations
1 site across 1 country: Canada
Source: ClinicalTrials.gov record NCT03799029. Inclusion in this directory is not an endorsement.